Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...
Researchers at Utah State University have reported a previously unrecognised CRISPR immune response in which a bacterial ...
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...
Scientists have uncovered a surprising viral shortcut that turns moving cells into delivery vehicles for infection. Instead ...
The film discusses the nature of viruses, including their structure, reproduction, and the diseases they cause. It explains how viruses are incredibly small and require a host cell to survive and ...
Researchers have discovered that virus-like nanoparticles can promote the multicellular organization and reproduction of host bacteria. These particles, which are evolutionarily related to phages ...
The mosquito-borne Zika virus hijacks a host protein called ANKLE2 to support its own reproduction. ANKLE2 is involved in brain development in the fetus and because Zika can cross the placenta and ...
The mosquito-borne Zika virus is known for causing microcephaly, a birth defect in which abnormal brain development results in a smaller-than-expected head. A new study published Jan. 13 in mBio shows ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results